RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership Changes & 13F Activity
RECURSION PHARMACEUTICALS-A (RXRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include ARK Invest, State Street Corp, Softbank Group Corp., Data Collective Iv Gp, Llc, and Charles Schwab Investment Management Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Roxbury Financial Llc | Buy | +1,000 | — | 1,000 | $4.13K | Q3 2026 | Oct 01, 2026 |
| Envestnet Asset Management Inc | Sell | -201,026 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 23, 2026 |
| State Street Corp | Sell | -34,706,130 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 22, 2026 |
| Anchor Investment Management, Llc | Sell | -347 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 15, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -253,791 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Sell | -2,000 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Sell | -128,478 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Sell | -51,561 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -560,196 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Sell | -26,612 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 19, 2026 |
| Beacon Pointe Advisors, Llc | Sell | -10,734 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 18, 2026 |
| Capstone Investment Advisors, Llc | Sell | -222,378 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 17, 2026 |
| Centaurus Financial, Inc. | Sell | -17,165 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 17, 2026 |
| ARK Invest | Sell | -41,337,632 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Softbank Group Corp. | Sell | -13,636,515 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Data Collective Iv Gp, Llc | Sell | -5,941,120 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -4,138,286 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Dcvc Opportunity Fund Ii Gp, Llc | Sell | -3,951,141 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -3,917,858 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -3,353,658 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -3,292,128 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -2,597,478 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -1,834,762 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Comprehensive Financial Management Llc | Sell | -941,895 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Invesco Ltd. | Sell | -795,698 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Group One Trading Llc | Sell | -783,035 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Man Group Plc | Sell | -765,786 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -720,097 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Vestmark Advisory Solutions, Inc. | Sell | -708,858 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Lazard Asset Management Llc | Sell | -692,378 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
Frequently asked questions about RXRX activity
Which institutional owners are buying RXRX?
Institutional owners buying RXRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in RXRX activity?
"Buy" means an investor increased their reported position in RXRX compared to the prior reporting period. This reflects growing exposure to RECURSION PHARMACEUTICALS-A (RXRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in RXRX increasing?
Institutional interest in RXRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related RXRX Institutional Insights
- RXRX Overview
- RXRX 13F Institutional Holders
- RXRX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RXRX Insider Trading & SEC Form 4 Activity
- RXRX Articles
- Top Institutional Investor Stock Rankings